vs

Side-by-side financial comparison of CME Group (CME) and ICON PLC (ICLR). Click either name above to swap in a different company.

ICON PLC is the larger business by last-quarter revenue ($2.0B vs $1.9B, roughly 1.1× CME Group). ICON PLC runs the higher net margin — 0.1% vs 0.1%, a 0.1% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 0.6%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs 0.6%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.

CME vs ICLR — Head-to-Head

Bigger by revenue
ICLR
ICLR
1.1× larger
ICLR
$2.0B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+13.9% gap
CME
14.5%
0.6%
ICLR
Higher net margin
ICLR
ICLR
0.1% more per $
ICLR
0.1%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
0.6%
ICLR

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CME
CME
ICLR
ICLR
Revenue
$1.9B
$2.0B
Net Profit
$1.2M
$2.4M
Gross Margin
Operating Margin
0.1%
4.2%
Net Margin
0.1%
0.1%
Revenue YoY
14.5%
0.6%
Net Profit YoY
20.7%
-98.8%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
ICLR
ICLR
Q1 26
$1.9B
Q4 25
$1.6B
Q3 25
$1.5B
$2.0B
Q2 25
$1.7B
$2.0B
Q1 25
$1.6B
$2.0B
Q4 24
$1.5B
Q3 24
$1.6B
$2.0B
Q2 24
$1.5B
$2.1B
Net Profit
CME
CME
ICLR
ICLR
Q1 26
$1.2M
Q4 25
$1.2B
Q3 25
$908.0M
$2.4M
Q2 25
$1.0B
$183.0M
Q1 25
$956.2M
$154.2M
Q4 24
$874.6M
Q3 24
$912.8M
$197.1M
Q2 24
$883.2M
$146.9M
Operating Margin
CME
CME
ICLR
ICLR
Q1 26
0.1%
Q4 25
61.8%
Q3 25
63.3%
4.2%
Q2 25
66.7%
10.4%
Q1 25
67.5%
11.0%
Q4 24
62.1%
Q3 24
64.6%
14.1%
Q2 24
65.3%
10.8%
Net Margin
CME
CME
ICLR
ICLR
Q1 26
0.1%
Q4 25
71.7%
Q3 25
59.1%
0.1%
Q2 25
60.6%
9.1%
Q1 25
58.2%
7.7%
Q4 24
57.3%
Q3 24
57.6%
9.7%
Q2 24
57.6%
6.9%
EPS (diluted)
CME
CME
ICLR
ICLR
Q1 26
Q4 25
$3.24
Q3 25
$2.49
$0.03
Q2 25
$2.81
$2.30
Q1 25
$2.62
$1.90
Q4 24
$2.40
Q3 24
$2.50
$2.36
Q2 24
$2.42
$1.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
ICLR
ICLR
Cash + ST InvestmentsLiquidity on hand
$2.4B
$468.9M
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$9.3B
Total Assets
$202.0B
$16.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
ICLR
ICLR
Q1 26
$2.4B
Q4 25
$4.5B
Q3 25
$2.6B
$468.9M
Q2 25
$2.1B
$390.4M
Q1 25
$1.5B
$526.7M
Q4 24
$3.0B
Q3 24
$2.4B
$695.5M
Q2 24
$1.9B
$506.6M
Total Debt
CME
CME
ICLR
ICLR
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
ICLR
ICLR
Q1 26
Q4 25
$28.7B
Q3 25
$28.2B
$9.3B
Q2 25
$27.7B
$9.6B
Q1 25
$27.0B
$9.5B
Q4 24
$26.5B
Q3 24
$28.2B
$9.8B
Q2 24
$27.6B
$9.6B
Total Assets
CME
CME
ICLR
ICLR
Q1 26
$202.0B
Q4 25
$198.4B
Q3 25
$187.1B
$16.5B
Q2 25
$179.9B
$16.6B
Q1 25
$157.8B
$16.7B
Q4 24
$137.4B
Q3 24
$137.8B
$17.2B
Q2 24
$123.4B
$17.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
ICLR
ICLR
Operating Cash FlowLast quarter
$387.6M
Free Cash FlowOCF − Capex
$333.9M
FCF MarginFCF / Revenue
16.3%
Capex IntensityCapex / Revenue
2.6%
Cash ConversionOCF / Net Profit
164.59×
TTM Free Cash FlowTrailing 4 quarters
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
ICLR
ICLR
Q1 26
Q4 25
$1.1B
Q3 25
$968.1M
$387.6M
Q2 25
$1.1B
$146.2M
Q1 25
$1.1B
$268.2M
Q4 24
$1.0B
Q3 24
$1.0B
$402.7M
Q2 24
$776.9M
$218.6M
Free Cash Flow
CME
CME
ICLR
ICLR
Q1 26
Q4 25
$1.1B
Q3 25
$949.7M
$333.9M
Q2 25
$1.0B
$113.9M
Q1 25
$1.1B
$239.3M
Q4 24
$991.7M
Q3 24
$973.2M
$359.3M
Q2 24
$758.7M
$182.3M
FCF Margin
CME
CME
ICLR
ICLR
Q1 26
Q4 25
66.8%
Q3 25
61.8%
16.3%
Q2 25
61.5%
5.6%
Q1 25
67.1%
12.0%
Q4 24
65.0%
Q3 24
61.4%
17.7%
Q2 24
49.5%
8.6%
Capex Intensity
CME
CME
ICLR
ICLR
Q1 26
Q4 25
2.0%
Q3 25
1.2%
2.6%
Q2 25
1.1%
1.6%
Q1 25
0.9%
1.4%
Q4 24
1.7%
Q3 24
1.9%
2.1%
Q2 24
1.2%
1.7%
Cash Conversion
CME
CME
ICLR
ICLR
Q1 26
Q4 25
0.96×
Q3 25
1.07×
164.59×
Q2 25
1.03×
0.80×
Q1 25
1.17×
1.74×
Q4 24
1.16×
Q3 24
1.10×
2.04×
Q2 24
0.88×
1.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

ICLR
ICLR

Other Customers$681.3M33%
Clients1125$549.4M27%
Clients15$503.3M25%
Clients610$308.8M15%

Related Comparisons